Eurotimes Articles

  • 05/01/2014 - 10:10 DME TREATMENT 2014, May, Retina Patients with diabetic macular oedema (DME) receiving intravitreal aflibercept (Eylea, Regeneron) every four or every eight weeks have superior visual acuity outcomes compared to patients treated with laser photocoagulation.
  • 04/01/2014 - 12:29 OPTOGENETICS INNOVATIONS 2014, April, Retina A rapidly evolving field of research known as optogenetics offers exciting potential for the restoration of vision in patients with incurable degenerative retinal diseases such as retinitis pigmentosa and advanced macular degeneration
  • 04/01/2014 - 12:24 MACULAR OEDEMA 2014, April, Retina While the exact pathogenesis of cystoid macular oedema (CME) remains uncertain, significant advances have been made in recent years in understanding the complex cellular and molecular processes involved in the disruption to the blood-retinal barrier (BRB) implicated in the development of CME
  • 04/01/2014 - 11:57 DIABETIC RETINOPATHY 2014, April, Retina Individualised screening as opposed to routine annual screening of diabetic patients for sightthreatening diabetic retinopathy delivers medical attention more efficiently to where it is needed, thereby achieving optimum results at minimum cost
  • 04/01/2014 - 11:40 AMD RADIOTHERAPY 2014, April, Retina Stereotactic radiotherapy (SRT) seems to offer a safe and efficacious treatment for neovascular age-related macular degeneration (AMD), with patients achieving a statistically significant reduction in ranibizumab retreatment after 24 months, according to Timothy L Jackson PhD, FRCOphth.
  • 03/03/2014 - 12:06 REALITY CHECK Mar, 2014, Retina Closer adherence to published protocols concerning anti- VEGF use, and more aggressive treatment of patients with neovascular AMD could help to improve visual outcomes in these patients, according to Frank Holz MD.
  • 03/03/2014 - 11:42 GOOD RESULTS Mar, 2014, Retina Newer small-gauge vitrectomy instruments can facilitate the dissection of all types of proliferative tissue in eyes with proliferative diabetic retinopathy, said Borja Corcostegui MD at the 13th EURETINA Congress in Hamburg.
  • 03/03/2014 - 11:40 GENE THERAPY Mar, 2014, Retina Gene therapy strategies have the potential to revolutionise management of a number of inherited retinal diseases in the future, according to Bart P Leroy MD, PhD.
  • 03/03/2014 - 11:32 ENDOPHTHALMITIS Mar, 2014, Retina In an effort to reduce the number of cases that develop endophthalmitis following intravitreal anti-VEGF injections, Peter Barry FRCS has extended an invitation to retinal specialists across Europe to participate in the newly launched ESCRS Endophthalmitis Registry.
  • 03/03/2014 - 11:13 BRIDGING THE GAP Mar, 2014, Retina A multimodal approach, combining spectral domain optical coherence tomography (SD-OCT) and fundus autofluorescence, can provide very useful means of quantifying the extent and morphology of atrophic lesions in eyes with geographic atrophy, said Ramzi G Sayegh MD, Medical University of Vienna, Vienna, Austria, at the 13th EURETINA Congress in Hamburg.

Popular Items